Ibaraki, Japan

Keigo Inosaka

This inventor holds 8 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Nitto-Denko Corporation, Kanebo, Limited. Active years: 2000-2013.

USPTO Granted Patents = 8 

% Patents Active = 50.0


 

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 29(Granted Patents)


Location History:

  • Osaka, JP (2000)
  • Ibaraki, JP (2000 - 2013)

Company Filing History:


Years Active: 2000-2013

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Keigo Inosaka: Innovator in Pharmaceutical Preparations

Introduction

Keigo Inosaka is a notable inventor based in Ibaraki, Japan, recognized for his contributions to the field of pharmaceutical preparations. With a total of eight patents to his name, Inosaka has made significant advancements in drug delivery systems.

Latest Patents

Inosaka's latest patents include a percutaneous absorption-type pharmaceutical preparation designed for stable drug administration. This innovative preparation ensures that the adhesive layer maintains its cohesive force even in the presence of sweat, preventing cohesive failure during wear. Another significant invention is an adhesive preparation that allows for a drug to be sufficiently dissolved in the adhesive layer, ensuring it does not easily separate during preservation. This preparation features a specific synthetic rubber and an organic liquid component, enhancing its effectiveness.

Career Highlights

Throughout his career, Inosaka has worked with prominent companies such as Nitto Denko Corporation and Kanebo, Limited. His experience in these organizations has contributed to his expertise in developing advanced pharmaceutical solutions.

Collaborations

Inosaka has collaborated with notable coworkers, including Takateru Muraoka and Hitoshi Akemi, further enriching his innovative endeavors.

Conclusion

Keigo Inosaka's work in pharmaceutical preparations showcases his dedication to improving drug delivery systems. His patents reflect a commitment to innovation and excellence in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…